Search

Your search keyword '"Rossing, M."' showing total 334 results

Search Constraints

Start Over You searched for: Author "Rossing, M." Remove constraint Author: "Rossing, M."
334 results on '"Rossing, M."'

Search Results

4. Completeness of RET testing in patients with medullary thyroid carcinoma in Denmark 1997–2013: a nationwide study

5. Clinical, splicing and functional analysis to classify BRCA2 exon 3 variants

6. Incidence and prevalence of multiple endocrine neoplasia 2A in Denmark 1901–2014: a nationwide study

7. Multigene profiles to guide the use of neoadjuvant chemotherapy for breast cancer:a Copenhagen Breast Cancer Genomics Study

8. Multigene profiles to guide the use of neoadjuvant chemotherapy for breast cancer:a Copenhagen Breast Cancer Genomics Study

11. Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers

13. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

14. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature Communications, (2021), 12, 1, (1078), 10.1038/s41467-020-20496-3).

15. Erratum: Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature communications (2021) 12 1 (1078)).

16. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

17. Characterization of the Cancer Spectrum in Men with Germline BRCA1 and BRCA2 Pathogenic Variants: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).

18. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (vol 12, 1078, 2021)

19. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

20. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

21. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

22. The spectrum of fancm protein truncating variants in European breast cancer cases.

23. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.

24. The Spectrum of FANCM Protein Truncating Variants in European Breast Cancer Cases

25. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

26. Quality improvement in clinical NGS through a peer-driven Nordic collaboration

27. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer.

28. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

29. Shared heritability and functional enrichment across six solid cancers

30. Publisher Correction: Shared heritability and functional enrichment across six solid cancers (Nature Communications, (2019), 10, 1, (431), 10.1038/s41467-018-08054-4)

31. Clinical and molecular characterization of BRCA-associated breast cancer:results from the DBCG

34. BRCA1 and BRCA2 5 ' noncoding region variants identified in breast cancer patients alter promoter activity and protein binding

35. Clinical and molecular characterization of BRCA-associated breast cancer:results from the DBCG

36. Genomic alterations accompanying tumour evolution in colorectal cancer:tracking the differences between primary tumours and synchronous liver metastases by whole-exome sequencing

37. Risk of Ovarian Cancer and the NF-? B Pathway: Genetic Association with IL1A and TNFSF10

39. PALB2, CHEK2 and ATM rare variants and cancer risk:data from COGS

40. Erratum: The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer

41. Menopausal hormone use and ovarian cancer risk : Individual participant meta-analysis of 52 epidemiological studies

42. Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies

43. Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study

44. Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk

46. Clinical and molecular characterization of BRCA -associated breast cancer: results from the DBCG.

47. Ovarian cancer and smoking: individual participant meta-analysis including 28 114 women with ovarian cancer from 51 epidemiological studies

48. Ovarian Cancer and Body Size: Individual Participant Meta-Analysis Including 25,157 Women with Ovarian Cancer from 47 Epidemiological Studies

50. Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23 257 women with ovarian cancer and 87 303 controls

Catalog

Books, media, physical & digital resources